Get the Stockscreener App
32.29
3.39%
1.06
After Hours:
32.29
Vor Biopharma Inc stock is traded at $32.29, with a volume of 291.40K.
It is up +3.39% in the last 24 hours and down -7.21% over the past month.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
See More
Previous Close:
$31.23
Open:
$31.5
24h Volume:
291.40K
Relative Volume:
0.87
Market Cap:
$214.05M
Revenue:
-
Net Income/Loss:
$-112.46M
P/E Ratio:
-19.69
EPS:
-1.64
Net Cash Flow:
$-99.89M
1W Performance:
-9.51%
1M Performance:
-7.21%
6M Performance:
+130.64%
1Y Performance:
+140.93%
1-Day Range:
$31.50
$33.17
1-Week Range:
$30.48
$35.82
52-Week Range:
$2.622
$65.80
Vor Biopharma Inc Stock (VOR) Company Profile
Name
Vor Biopharma Inc
Sector
Industry
Phone
617-655-6580
Address
100 CAMBRIDGEPARK DRIVE, CAMBRIDGE
Compare VOR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VOR
Vor Biopharma Inc
|
32.29 | 214.05M | 0 | -112.46M | -99.89M | -1.64 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Vor Biopharma Inc Stock (VOR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Upgrade | Stifel | Hold → Buy |
| Jun-30-25 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Jul-26-22 | Initiated | Wedbush | Outperform |
| Apr-27-22 | Initiated | Goldman | Neutral |
| Dec-17-21 | Initiated | H.C. Wainwright | Buy |
| Dec-03-21 | Initiated | Robert W. Baird | Outperform |
| Dec-02-21 | Initiated | Oppenheimer | Outperform |
| Oct-19-21 | Initiated | JMP Securities | Mkt Outperform |
| Mar-25-21 | Initiated | B. Riley Securities | Buy |
| Mar-03-21 | Initiated | Barclays | Overweight |
| Mar-03-21 | Initiated | Evercore ISI | Outperform |
| Mar-02-21 | Initiated | Goldman | Sell |
| Mar-02-21 | Initiated | Stifel | Buy |
View All
Vor Biopharma Inc Stock (VOR) Latest News
Can machine learning forecast Vor Biopharma Inc. recoveryJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - newser.com
Can Vor Biopharma Inc. stock resist sector downturnsPortfolio Return Summary & Precise Entry and Exit Recommendations - newser.com
Can Vor Biopharma Inc. stock maintain operating marginsJuly 2025 Rallies & Real-Time Volume Analysis - newser.com
Vor Biopharma Inc. (NASDAQ:VOR) Receives Consensus Rating of "Hold" from Analysts - MarketBeat
Reprogrammed Interchange Llc Sells 48,884 Shares of Vor Biopharma (NASDAQ:VOR) Stock - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Sells $2,549,123.94 in Stock - MarketBeat
Vor Biopharma Inc.'s (NASDAQ:VOR) Intrinsic Value Is Potentially 55% Above Its Share Price - simplywall.st
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock By Investing.com - Investing.com Australia
Vor Biopharma (VOR) 10% owner sells $4.1 million in stock - Investing.com
Is Vor Biopharma Inc. stock poised for growth2025 Key Highlights & High Return Stock Watch Alerts - newser.com
Reversal indicators forming on Vor Biopharma Inc. stock2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
What indicators show strength in Vor Biopharma Inc.Portfolio Performance Summary & Weekly High Potential Stock Alerts - newser.com
What analyst consensus says on Vor Biopharma Inc. stock2025 Retail Activity & Free Daily Entry Point Trade Alerts - newser.com
Is Vor Biopharma Inc. meeting your algorithmic filter criteria2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com
Vor Biopharma's (VOR) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Vor Biopharma (NASDAQ:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 70,763 Shares - MarketBeat
Vor biopharma $3.5m stock sale by ten percent owner - Investing.com Australia
Relative strength of Vor Biopharma Inc. in sector analysisJuly 2025 Trade Ideas & Free Technical Confirmation Trade Alerts - newser.com
Published on: 2025-10-09 02:38:01 - newser.com
Vor biopharma $3.5m stock sale by ten percent owner By Investing.com - Investing.com Australia
Can momentum traders help lift Vor Biopharma Inc.Dividend Hike & Low Risk Investment Opportunities - newser.com
Applying sector rotation models to Vor Biopharma Inc.2025 Key Lessons & Consistent Growth Equity Picks - newser.com
Will Vor Biopharma Inc. bounce back from current support2025 Price Momentum & Growth Oriented Trade Recommendations - newser.com
Reprogrammed Interchange Llc Sells 7,901 Shares of Vor Biopharma (NYSE:VOR) Stock - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 32,451 Shares - MarketBeat
Vor Biopharma (NYSE:VOR) Major Shareholder Reprogrammed Interchange Llc Sells 1,400 Shares - MarketBeat
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
What’s the recovery path for long term holders of Vor Biopharma Inc.July 2025 PostEarnings & High Return Trade Opportunity Guides - newser.com
76,360 Stock Options — Vor Bio Grants Options at $30.40 and RSUs to New Hires - Stock Titan
Tick level data insight on Vor Biopharma Inc. volatilityJuly 2025 Sector Moves & Breakout Confirmation Trade Signals - newser.com
Published on: 2025-10-03 00:08:46 - newser.com
Vor Bio Surges: Analysts See Bright Future - timothysykes.com
Published on: 2025-09-30 05:10:46 - newser.com
Vor Biopharma (VOR) Price Target Increased by 2,942.55% to 36.46 - Nasdaq
Vor Biopharma | EFFECT: Others - 富途牛牛
Vor Bio Announces Late-Breaking Poster Presentation of - GlobeNewswire
Vor Biopharma Inc Stock (VOR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vor Biopharma Inc Stock (VOR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Reprogrammed Interchange LLC | 10% Owner |
Oct 09 '25 |
Sale |
32.07 |
48,884 |
1,567,611 |
1,374,775 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 06 '25 |
Sale |
37.01 |
70,763 |
2,618,788 |
1,526,545 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 07 '25 |
Sale |
33.84 |
27,624 |
934,711 |
1,498,921 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 02 '25 |
Sale |
39.83 |
32,451 |
1,292,457 |
1,605,209 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 03 '25 |
Sale |
37.83 |
7,901 |
298,911 |
1,597,308 |
| Reprogrammed Interchange LLC | 10% Owner |
Oct 01 '25 |
Sale |
39.19 |
1,400 |
54,870 |
1,637,660 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 16 '25 |
Sale |
1.54 |
447,278 |
688,853 |
32,781,209 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 15 '25 |
Sale |
1.64 |
400,000 |
656,320 |
33,228,487 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 12 '25 |
Sale |
1.75 |
300,000 |
526,230 |
33,628,487 |
| Reprogrammed Interchange LLC | 10% Owner |
Sep 11 '25 |
Sale |
1.83 |
284,805 |
521,421 |
33,928,487 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):